Barrow, Hanley, Mewhinney & Strauss’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
Barrow, Hanley, Mewhinney & Strauss's ACLS Position: Q2 2026 in Review
Barrow, Hanley, Mewhinney & Strauss increased its Axcelis (ACLS) stake by 688,040% in Q2 2026, buying an estimated $58.2M and bringing the position to 392,240 shares worth $74.3M. The position accounts for 0.23% of the portfolio, ranked #100.
Barrow, Hanley, Mewhinney & Strauss first reported a position in ACLS in Q2 2025 and has held it in 3 quarters since. 440 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Barrow, Hanley, Mewhinney & Strauss held 392,240 shares of Axcelis worth $74.3M as of Q2 2026.
- Barrow, Hanley, Mewhinney & Strauss bought 392,183 Axcelis shares in Q2 2026, an estimated $58.2M.
- Axcelis made up 0.23% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q2 2026, its #100 holding.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in Axcelis in Q2 2025 and has held it in 3 quarters since.
- 440 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.